The purpose of this study is to determine whether the daily eating of a yogurt supplemented with Mobile is effective in improving joint function and quality of life of individuals with low intensity gonalgia.
The prevalence of low intensity gonalgia is relatively high in western population. The purpose of the present intervention study is to determine whether the daily consumption of a yogurt supplemented with Mobile is effective in improving joint function and quality of life of individuals with low intensity gonalgia. Previous research using in vitro and animal models have demonstrated the efficacy of Mobilee in reducing inflammation and promoting anabolic responses in joint tissues. In addition, in two previous human intervention trials, the effects of Mobilee in joint function had been assessed using isokinetic tests. The present trial aims to confirm those previous results.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
80
One yogurt (125mL) per day including 80mg of Mobilee
One yogurt (125mL) per day
Hospital Universitari Sant Joan de Reus
Reus, Tarragona, Spain
Change from baseline in isokineic assessment of muscular strength
The muscular isokinetic assessment determines peak torque, power mean and total work of a certain joint using a dynamometric computerized system. The principal parameter is the change from baseline in the peak torque of the affected joint in extension at a speed of 240º/sec measured in Nm (Newton-meter).
Time frame: 3 months
Change from baseline in isokinetic assessment of muscular strength (other conditions)
Change from baseline of peak torque (Nm), power mean (W) and total work (J) of the affected joint in extension at 180º/sec, and in flexion at 240º/sec and 180º/sec.
Time frame: 3 months
Assessment of joint swelling, effusion
Ultrasonography: Study of the synovial effusion degree (if any) measured in the longitudinal axis of the suprapatellar recess of the affected knee.Results are expressed as change from baseline in mm.
Time frame: 3 months
Pain assessment (VAS)
Time evolution of pain intensity as measured by Visual Analogue Scale (mm).
Time frame: 3 months
SF-36 Health questionnaire
Questionnaire SF36-v2 to measure physical and mental health.
Time frame: 3 months
Number of Participants with Adverse Events
The safety assessment includes a register of the appearance of adverse events along the 3 months of the study
Time frame: 3 months
Subjective evaluation of the intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Questionnaire to evaluate the subjective perception of the efficacy of the intervention.
Time frame: 3 months
Change from baseline in systolic blood pressure, hearth rate, general biochemical profile and body mass index at 3 months
Safety assessment includes an evaluation at 3 months of changes from baseline on systolic blood pressure, hearth rate, general biochemical profile and body mass index
Time frame: 3 months